Oncology Nurse Edition Contact Us
Editorial Inquiries:Anne Landry, Executive Editor Ph: 212-929-4624 Email: anne.landry@ubm.comContinuing Education: Marsha Peruo Ph: 201-984-6216 Email: marsha.peruo@cmellc.comEditorial Office: UBM Medica LLC 535 Connecticut Ave, Suite 300 Norwalk, CT 06854 Ph: 516-474-4766Publisher and Sales Contacts: Amy Birnbach Group Publisher Ph: 201-984-6265 Email: amy.birnbach@ubm.com Sarah Mifsud Account Manager Digital Media Ph: 203-523-7055 Email: sarah.mifsud@ubm.comWeb site Contact: Ian Ingram Web Editor Email: ian.ingram@ubm.com
CONTACT US
Editorial Inquiries:
Anne Landry, Executive Editor
Ph: 212-929-4624
Email: anne.landry@ubm.comContinuing Education:
Marsha Peruo
Ph: 201-984-6216
Email: marsha.peruo@cmellc.comEditorial Office:
UBM Medica LLC
535 Connecticut Ave, Suite 300
Norwalk, CT 06854
Ph: 516-474-4766
Publisher and Sales Contacts:
Amy Birnbach
Group Publisher
Ph: 201-984-6265
Email: amy.birnbach@ubm.com
Sarah Mifsud
Account Manager
Digital Media
Ph: 203-523-7055
Email: sarah.mifsud@ubm.comWeb site Contact:
Ian Ingram
Web Editor
Email: ian.ingram@ubm.com
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
![We found that patients who are [complete remission] MRD-negative, and PET/CT negative year after year for 5 years do not have to be maintained.](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2Fa0c5316b5733cfe8ccceb396476faf0cea2f2e46-320x410.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "We found that patients who are [complete remission] MRD-negative, and PET/CT negative year after year for 5 years do not have to be maintained.")
